Market Research Logo

NeuroDerm Ltd - Product Pipeline Analysis, 2018 Update

Summary

NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s liquid formulation of levodopa/carbidopa product candidates includes ND0612L, intended for moderate Parkinson’s diseases; and ND0612H, for severe Parkinson’s disease. It also develops ND0701, intended for patients with severe Parkinson’s disease and ND0801, a product candidate intended for the treatment of cognitive disorders associated with CNS diseases including attention deficit disorder or attention deficit hyperactivity disorder, schizophrenia, alzheimer’s disease, and other diseases. NeuroDerm is headquartered in Rehovot, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company NeuroDerm Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


NeuroDerm Ltd Company Overview
NeuroDerm Ltd Company Snapshot NeuroDerm Ltd Pipeline Products and Ongoing Clinical Trials Overview NeuroDerm Ltd – Pipeline Analysis Overview NeuroDerm Ltd - Key Facts NeuroDerm Ltd - Major Products and Services NeuroDerm Ltd Pipeline Products by Development Stage NeuroDerm Ltd Ongoing Clinical Trials by Trial Status NeuroDerm Ltd Pipeline Products Overview CRONO ND CRONO ND Product Overview CRONO Twin ND CRONO Twin ND Product Overview CRONO Twin ND Clinical Trial ND0601 Dermal Patch ND0601 Dermal Patch Product Overview ND0611 Dermal Patch ND0611 Dermal Patch Product Overview ND0612H Belt Pump ND0612H Belt Pump Product Overview ND0612L Patch Pump ND0612L Patch Pump Product Overview ND0612L Patch Pump Clinical Trial ND0901 ND0901 Product Overview NeuroDerm Ltd - Key Competitors NeuroDerm Ltd - Key Employees NeuroDerm Ltd - Locations And Subsidiaries Head Office Recent Developments NeuroDerm Ltd, Recent Developments Aug 03, 2017: NeuroDerm Announces Second Quarter 2017 Financial Results Jun 27, 2017: Results of NeuroDerm’s ND0612H Phase II Trial Presented in Oral Session at the 3rd Congress of the European Academy of Neurology Jun 08, 2017: NeuroDerm Presents Six Posters at the 21st International Congress of Parkinson’s Disease and Movement Disorders Jun 06, 2017: European Medicines Agency Accepts Design of NeuroDerm’s ND0612 Phase III iNDiGO Efficacy Trial Jun 05, 2017: NeuroDerm Presents ND0612H Phase II Trial Results in Late-Breaking Poster Session at the 21st International Congress of Parkinson’s Disease and Movement Disorders May 23, 2017: NeuroDerm ND0612H Phase II Trial Results to be Presented in Late-Breaking Session at the 21st International Congress of Parkinson’s Disease and Movement Disorders May 11, 2017: NeuroDerm Announces First Quarter 2017 Financial Results Mar 30, 2017: NeuroDerm Announces Fourth Quarter and Full Year 2016 Financial Results Mar 01, 2017: NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease; Seeks Broader EU Label Based on iNDiGO Trial Following EMA Meeting Dec 22, 2016: NeuroDerm Announces Completion of Patient Enrollment and Treatment in a Phase II Trial of ND0612H for Advanced Parkinson’s Disease
Appendix
Methodology About GlobalData Contact Us Disclaimer
List of Tables
NeuroDerm Ltd Pipeline Products and Ongoing Clinical Trials Overview
NeuroDerm Ltd Pipeline Products by Equipment Type
NeuroDerm Ltd Pipeline Products by Indication
NeuroDerm Ltd Ongoing Clinical Trials by Trial Status
NeuroDerm Ltd, Key Facts
NeuroDerm Ltd, Major Products and Services
NeuroDerm Ltd Number of Pipeline Products by Development Stage
NeuroDerm Ltd Pipeline Products Summary by Development Stage
NeuroDerm Ltd Ongoing Clinical Trials by Trial Status
NeuroDerm Ltd Ongoing Clinical Trials Summary
CRONO ND - Product Status
CRONO ND - Product Description
CRONO Twin ND - Product Status
CRONO Twin ND - Product Description
CRONO Twin ND - A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/carbidopa Delivered via a Pump System as a Continuous Subcutaneous Infusion in Subjects with Advanced Parkinson's Disease
CRONO Twin ND - A Phase III Randomized, Open-Label, Multi-center, Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy Versus Standard of Care Platinum-based Chemotherapy in First Line Treatment of Patients with Advanced or Metastatic Non Small-cell Lung Cancer (NSCLC): MYSTIC
ND0601 Dermal Patch - Product Status
ND0601 Dermal Patch - Product Description
ND0611 Dermal Patch - Product Status
ND0611 Dermal Patch - Product Description
ND0612H Belt Pump - Product Status
ND0612H Belt Pump - Product Description
ND0612L Patch Pump - Product Status
ND0612L Patch Pump - Product Description
ND0612L Patch Pump - A Follow-up Comparison Pharmacokinetic Study of ND-0701 (Apomorphine)
ND0901 - Product Status
ND0901 - Product Description
NeuroDerm Ltd, Key Employees
Glossary
List of Figures
NeuroDerm Ltd Pipeline Products by Equipment Type
NeuroDerm Ltd Pipeline Products by Development Stage
NeuroDerm Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook